Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.39 |
| ▸ | RXRA | P19793 | 2/20 | 0.39 |
| ▸ | PPARA | Q07869 | 2/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | GABRP | O00591 | 2/20 | 0.38 |
| ▸ | GABRD | O14764 | 2/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.38 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7877999 | 0.88 | GABRP (0.42) | RXRAPPARAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL5387844 | 0.87 | SLC16A3 (0.43) | PTPN1PTPN11RXRAPPARAMCL1 | |
| SCHEMBL5397794 | 0.85 | MEN1 (0.54) | PTPN1PTPN11RXRAMEN1KMT2A | |
| SCHEMBL9150935 | 0.81 | CA12 (0.45) | MEN1KMT2AL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL80902 | 0.79 | RXRA (0.52) | PTPN1PTPN11RXRAPPARAMCL1 | |
| SCHEMBL4914947 | 0.78 | GABRP (0.49) | RXRAPPARAMCL1SMN1; SMN2KDM4E | |
| SCHEMBL9745 | 0.77 | PTPN1 (0.54) | PTPN1PTPN11PPARAMCL1SMN1; SMN2 | |
| SCHEMBL3840599 | 0.77 | RXRA (0.51) | PTPN1PTPN11RXRAPPARAMCL1 | |
| SCHEMBL2809370 | 0.77 | CSNK2A1 (0.48) | PTPN1PTPN11RXRAPPARAMCL1 | |
| SCHEMBL15344558 | 0.77 | PPARA (0.53) | PTPN1PTPN11RXRAPPARAMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1740152-B1 | POLY(SILSESQUIOXANE) SPHERICAL PARTICLE CONTAINING ULTRAVIOLET LIGHT-ABSORBING GROUP AND MANUFACTURING METHOD THEREOF | SAIMDANG COSMETICS CO LTD (KR) | 2012-12-26 | — | — | EP | claimed |
| US-7964747-B2 | Poly(silsesquioxane) spherical particle containing ultraviolet light-absorbing group and manufacturing method thereof | Saimdang Cosmetics, Co., Ltd. (KR) | 2011-06-21 | — | — | US | claimed |
| US-20070249854-A1 | Poly(Silsesquioxane) Spherical Particle Containing Ultraviolet Light-Absorbing Group and Manufacturing Method Thereof | SAIMDANG COSMETICS CO., LTD. (KR) | 2007-10-25 | — | — | US | claimed |
| EP-1740152-A1 | POLY(SILSESQUIOXANE) SPHERICAL PARTICLE CONTAINING ULTRAVIOLET LIGHT-ABSORBING GROUP AND MANUFACTURING METHOD THEREOF | Saimdang Cosmetics Co., Ltd. (KR) | 2007-01-10 | — | — | EP | claimed |
| WO-2005105028-A1 | POLY(SILSESQUIOXANE) SPHERICAL PARTICLE CONTAINING ULTRAVIOLET LIGHT-ABSORBING GROUP AND MANUFACTURING METHOD THEREOF | SAIMDANG COSMETICS CO., LTD. (KR) | 2005-11-10 | — | — | WO | claimed |
| EP-1740152-B1 | POLY(SILSESQUIOXANE) SPHERICAL PARTICLE CONTAINING ULTRAVIOLET LIGHT-ABSORBING GROUP AND MANUFACTURING METHOD THEREOF | SAIMDANG COSMETICS CO LTD (KR) | 2012-12-26 | — | — | EP | disclosed |
| US-7993630-B2 | Protection of skin from UV and peroxide | BIODERM RESEARCH (US) | 2011-08-09 | — | — | US | disclosed |
| US-7964747-B2 | Poly(silsesquioxane) spherical particle containing ultraviolet light-absorbing group and manufacturing method thereof | Saimdang Cosmetics, Co., Ltd. (KR) | 2011-06-21 | — | — | US | disclosed |
| US-20090269291-A1 | Protection of Skin from UV and Peroxide | BIODERM RESEARCH (US) | 2009-10-29 | — | — | US | disclosed |
| US-7597879-B2 | Sunscreen safety and efficacy enhancement | BIODERM RESEARCH (US) | 2009-10-06 | — | — | US | disclosed |
| US-20070249854-A1 | Poly(Silsesquioxane) Spherical Particle Containing Ultraviolet Light-Absorbing Group and Manufacturing Method Thereof | SAIMDANG COSMETICS CO., LTD. (KR) | 2007-10-25 | — | — | US | disclosed |
| US-20070189992-A1 | Sunscreen Safety and Efficacy Enhancement with Manganese Complexes via Urocanate Pathway | BIODERM RESEARCH (US) | 2007-08-16 | — | — | US | disclosed |
| EP-1740152-A1 | POLY(SILSESQUIOXANE) SPHERICAL PARTICLE CONTAINING ULTRAVIOLET LIGHT-ABSORBING GROUP AND MANUFACTURING METHOD THEREOF | Saimdang Cosmetics Co., Ltd. (KR) | 2007-01-10 | — | — | EP | disclosed |
| WO-2005105028-A1 | POLY(SILSESQUIOXANE) SPHERICAL PARTICLE CONTAINING ULTRAVIOLET LIGHT-ABSORBING GROUP AND MANUFACTURING METHOD THEREOF | SAIMDANG COSMETICS CO., LTD. (KR) | 2005-11-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249854-A1 | Poly(Silsesquioxane) Spherical Particle Containing Ultraviolet Light-Absorbing Group and Manufacturing Method Thereof | STS, PARG, SBDS | PTPN1 4393/4885PTPN11 4358/4885RXRA 1195/4885 |
| US-20090269291-A1 | Protection of Skin from UV and Peroxide | SOD3, UROD, SOD1 | PTPN1 3595/4885PTPN11 3722/4885RXRA 172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.